Conran Design Group

News

Global branding firm Conran Design Group has appointed former Wolff Olins chief operating officer Christina Falzano as its US managing director.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.